Nucleotides consist of a nitrogenous base, a pentose sugar, and phosphate groups. The nitrogenous bases fall into purines—adenine and guanine—and pyrimidines—cytosine, thymine (DNA only), and uracil (RNA only) [1]. The pentose sugar varies between ribose in RNA and deoxyribose in DNA. Phosphate groups can occur as mono-, di-, or triphosphates, linking nucleotides into polymers and serving as energy currency. In addition to their role in nucleic acids, nucleotides are used as flavour enhancers in the form of 5-nucleotides to enhance the umami taste [1].
Pyrimidine nucleotide biosynthesis initiates with carbamoyl phosphate synthesis from glutamine and carbon dioxide. Subsequently, aspartate carbamoyltransferase catalyzes the condensation of carbamoyl phosphate with aspartate to form carbamoyl aspartic acid, which cyclizes to 4,5-dihydroorotic acid. This intermediate undergoes oxidation by dihydroorotate oxidase:
\[
(S)\text{-Dihydroorotate} + \mathrm{O_2} \rightarrow \mathrm{Orotate} + \mathrm{H_2O_2}
\]
The orotate produced attaches covalently to a ribosyl unit derived from 5-phospho-\(\alpha\)-D-ribose 1-diphosphate (PRPP). This reaction, catalyzed by orotate phosphoribosyltransferase (PRPP transferase), yields orotidine 5'-monophosphate (OMP):
\[
\mathrm{Orotate} + \mathrm{PRPP} \rightarrow \mathrm{Orotidine\;5'}\text{-}\mathrm{phosphate} + \mathrm{Pyrophosphate}
\]
OMP then undergoes decarboxylation via orotidine-5'-phosphate decarboxylase to generate uridine monophosphate (UMP). PRPP transferase catalyzes both the ribosylation and decarboxylation reactions, forming UMP from orotic acid in the presence of PRPP. UMP serves as the precursor for other pyrimidine nucleotides through phosphorylation reactions:
\[
\mathrm{ATP} + \mathrm{UMP} \rightarrow \mathrm{ADP} + \mathrm{UDP}
\]
followed by
\[
\mathrm{UDP} + \mathrm{ATP} \rightarrow \mathrm{UTP} + \mathrm{ADP}
\]
CTP synthetase catalyzes the amination of UTP to cytidine triphosphate (CTP), utilizing glutamine as the ammonia donor and hydrolyzing ATP:
\[
\mathrm{UTP} + \mathrm{Glutamine} + \mathrm{ATP} + \mathrm{H_2O} \rightarrow \mathrm{CTP} + \mathrm{ADP} + \mathrm{Pi}
\]
Cytidine monophosphate (CMP) results from CTP through loss of two phosphate groups, completing the set of pyrimidine ribonucleotides ready for incorporation into RNA or further modification for DNA synthesis [1].
Purines assemble their characteristic double-ring structure directly onto a ribose-phosphate scaffold provided by PRPP. Several enzymes orchestrate stepwise ring construction using amino acids such as glycine, glutamine, and aspartate, along with carbon dioxide and tetrahydrofolate derivatives contributing one-carbon units. The syntheses of the purine and pyrimidine nucleotides are carried out by several enzymes in the cytoplasm of the cell, not within a specific organelle [1].
The purine ring assembly commences on PRPP’s ribose moiety rather than attaching a preformed base. This strategy contrasts with pyrimidine synthesis where the base forms first before ribosyl attachment. The complete purine nucleotide formed initially is inosine monophosphate (IMP), which serves as a branching point for AMP and GMP biosynthesis pathways.
Cells recycle free bases and nucleosides salvaged from nucleotide degradation or extracellular sources back into nucleotides through salvage pathways. These routes conserve metabolic energy compared to de novo synthesis and depend heavily on substrate availability and transporter activity (e.g., ENT/SLC29 and CNT/SLC28 carriers) across cellular membranes [4].
Salvage enzymes like hypoxanthine-guanine phosphoribosyltransferase (HGPRT) recover guanine and hypoxanthine bases by attaching them to PRPP, regenerating GMP and IMP respectively. Similarly, thymidine kinase phosphorylates thymidine salvaged from DNA breakdown back into TMP.
Cancer cells exploit both de novo synthesis and salvage pathways variably depending on nutrient availability within tumor microenvironments. When extracellular nucleoside supply is limited but metabolic capacity supports robust biosynthesis, cells lean on de novo pathways. Conversely, abundant extracellular nucleosides favor salvage pathway usage [4].
Rate-limiting enzymes include amidophosphoribosyltransferase in purine biosynthesis and carbamoyl phosphate synthetase II in pyrimidine production. These enzymes are subject to feedback inhibition by downstream nucleotides ensuring homeostasis.
Energy-intensive phosphorylation steps utilize ATP hydrolysis not only to drive unfavorable reactions forward but also integrate nucleotide metabolism with cellular energetic status. For instance, phosphorylation of UMP to UDP consumes one ATP molecule per reaction cycle [1].
Nucleotide biosynthesis draws precursors from central carbon metabolism including glycolysis-derived ribose 5-phosphate via the pentose phosphate pathway, amino acids from protein turnover or diet such as glutamine and aspartate, as well as one-carbon donors from folate metabolism.
Mitochondrial function influences pyrimidine synthesis capacity since dihydroorotate dehydrogenase relies on mitochondrial respiratory chain components for oxidation of dihydroorotate [4].
Nucleotides polymerize through phosphodiester bonds linking the 3' hydroxyl group of one sugar to the 5' phosphate group of another nucleotide’s sugar—giving rise to strand directionality indicated by free ends termed 5'-end and 3'-end [1]. Complementary base pairing stabilizes double-stranded DNA: adenine forms a base pair with thymine with two hydrogen bonds, while guanine pairs with cytosine with three hydrogen bonds [1].
Signaling cyclic nucleotides differ structurally by forming intramolecular phosphodiester bonds bridging the sugar’s 5' and 3' hydroxyls; examples include cyclic AMP (cAMP) and cyclic GMP (cGMP) [1].
Generating summary…